4583 — Chiome Bioscience Balance Sheet
0.000.00%
Last trade - 00:00
- ¥7bn
- ¥6bn
- ¥682m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 2,106 | 2,686 | 1,791 | 1,727 | 1,326 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 131 | 114 | 61.5 | 145 | 108 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,561 | 3,249 | 2,217 | 2,092 | 1,629 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 11.1 | 7.16 | 4.2 | 2.44 | 1.17 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 2,808 | 3,495 | 2,339 | 2,215 | 1,751 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 145 | 343 | 393 | 370 | 539 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 187 | 385 | 446 | 425 | 594 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 2,622 | 3,110 | 1,893 | 1,791 | 1,158 |
Total Liabilities & Shareholders' Equity | 2,808 | 3,495 | 2,339 | 2,215 | 1,751 |
Total Common Shares Outstanding |